Suppr超能文献

两个细胞毒性T淋巴细胞表位和三个锚定残基在一个与H-2Ld结合且被抗小鼠肿瘤P815的细胞毒性T淋巴细胞识别的九聚体肽段上的定位。

Localization of two cytotoxic T lymphocyte epitopes and three anchoring residues on a single nonameric peptide that binds to H-2Ld and is recognized by cytotoxic T lymphocytes against mouse tumor P815.

作者信息

Van den Eynde B, Mazarguil H, Lethé B, Laval F, Gairin J E

机构信息

Ludwig Institute for Cancer Research, Brussels Branch.

出版信息

Eur J Immunol. 1994 Nov;24(11):2740-5. doi: 10.1002/eji.1830241125.

Abstract

Mouse mastocytoma P815 expresses tumor antigens P815A and P815B encoded by a single gene called P1A and carried by a single peptide named P1A 35-43 (NH2-Leu-Pro-Tyr-Leu-Gly-Trp-Leu-Val-Phe-COOH). P1A 35-43 is presented to anti-P815A and anti-P815B cytotoxic T lymphocytes (CTL) by major histocompatibility complex (MHC) H-2Ld molecules. In order to determine the individual role played by each amino acid residue of P1A 35-43 in binding to H-2Ld and in recognition by anti-A and anti-B T cell receptors (TcR), a series of P1A35-43 peptides substituted by alanine at single positions was synthesized and tested for binding to H-2Ld and for CTL recognition. Binding to H-2Ld was estimated by measuring the ability of the peptide to up-regulate cell surface expression of H-2Ld. We found that three residues were important for interaction of P1A 35-43 with H-2Ld. Two of them, Pro at position 2 and Phe at position 9 were consistent with the described H-2Ld binding motif. A third residue, Trp at position 6, was also required for effective MHC binding of the tumor antigen. CTL sensitization assays showed that alanine substitution at position 7 (Leu) or at position 8 (Val) dramatically affected peptide recognition by anti-A CTL while positions 3 (Tyr) and 4 (Leu) were critical for recognition by anti-B CTL. We conclude that Pro2, Trp6 and Phe9 constitute the anchor residues of P1A 35-43 to H-2Ld, whereas the dipeptidyl sequences Tyr3-Leu4 and Leu7-Val8 form the core epitopes recognized by the TcR of anti-P815B and anti-P815A CTL, respectively.

摘要

小鼠肥大细胞瘤P815表达由名为P1A的单个基因编码的肿瘤抗原P815A和P815B,该基因由名为P1A 35 - 43(NH2 - Leu - Pro - Tyr - Leu - Gly - Trp - Leu - Val - Phe - COOH)的单个肽段携带。P1A 35 - 43由主要组织相容性复合体(MHC)H - 2Ld分子呈递给抗P815A和抗P815B细胞毒性T淋巴细胞(CTL)。为了确定P1A 35 - 43的每个氨基酸残基在与H - 2Ld结合以及被抗A和抗B T细胞受体(TcR)识别中所起的个体作用,合成了一系列在单个位置被丙氨酸取代的P1A35 - 43肽段,并测试其与H - 2Ld的结合以及CTL识别能力。通过测量肽段上调H - 2Ld细胞表面表达的能力来评估与H - 2Ld的结合。我们发现三个残基对于P1A 35 - 43与H - 2Ld的相互作用很重要。其中两个,第2位的Pro和第9位的Phe与所描述的H - 2Ld结合基序一致。第三个残基,第6位的Trp,对于肿瘤抗原与MHC的有效结合也是必需的。CTL致敏试验表明,第7位(Leu)或第8位(Val)的丙氨酸取代显著影响抗A CTL对肽段的识别,而第3位(Tyr)和第4位(Leu)对于抗B CTL的识别至关重要。我们得出结论,Pro2、Trp6和Phe9构成P1A 35 - 43与H - 2Ld的锚定残基,而二肽序列Tyr3 - Leu4和Leu7 - Val8分别形成抗P815B和抗P815A CTL的TcR识别的核心表位。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验